Revvity Inc.

$90.50
(as of Jun 5, 7:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Ticker Information for Revvity Inc.

Stock Price
$90.50
Ticker Symbol
RVTY
Exchange
NYSE

Industry Information for Revvity Inc.

Sector
Healthcare
Industry
Diagnostics & Research

Company Description for Revvity Inc.

Country
USA
Full Time Employees
11,000

Revvity, Inc. provides health sciences solutions, technologies, and services worldwide. The company's Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and DNA sequencing services. Its Diagnostics segment offers instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. It also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for use in oncology, screening newborns for rare genetic conditions, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific, BioQule, BoBs, chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPatternTM, Evolution Evoya, explorer, Fontus, GSP, Haoyuan, IDS Immunodiagnosticsystems, IDS-i10, IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Omni Bead Ruptor, Omni Bead Ruptor Elite, Omni Tip, Pannoramic, Panthera Puncher, PG-Seq, PG-Find, PreNAT II, Prime, Protein Clear, ProteinEXact, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate, Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord, VICTOR2D, and Zephyr brands. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Mass

Fundamentals for Revvity Inc.

Market Capitalization
$11,292,616,704
EBITDA
$847,916,992
Dividends per Share
$0.28
P/E Ratio
38.84
Forward P/E Ratio
18.98
Earnings per Share
$2.42
Earnings per Share Estimate Next Year
Profit Margin
10.35%
Shares Outstanding
120,147,000
Percent Owned by Insiders
0.33%
Percent Owned by Institutions
95.13%
52-Week High
52-Week Low

Technical Indicators for Revvity Inc.

50-Day Moving Average
200-Day Moving Average
RSI
45.38
3.02

Analyst Ratings for Revvity Inc.

Strong Buy
10
Buy
4
Hold
6
Sell
0
Strong Sell
0

News About Revvity Inc.

Jun 5, 2025, 11:31 AM EST
It has been about a month since the last earnings report for Pediatrix Medical Group (MD). See more.
Jun 4, 2025, 12:36 AM EST
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. See more.
Jun 2, 2025, 8:00 AM EST
Revvity launches its first set of IVD Mimix reference standards, providing diagnostic labs with trusted quality controls for optimizing tests and monitoring workflows See more.
May 30, 2025, 1:04 PM EST
Revvity (NYSE:RVTY) has had a rough three months with its share price down 18%. See more.